Pharmala Biotech Holdings Inc. (CSE:MDMA)

Market Cap	15.00M
Revenue	n/a
Net Income	n/a
Shares Out	103.45M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	55,727
Average Volume	84,565
Open	0.1400
Previous Close	0.1400
Day's Range	0.1400 - 0.1500
52-Week Range	0.0650 - 0.3400
Beta	1.38
RSI	39.81
Earnings Date	n/a

About Pharmala Biotech Holdings

Pharmala Biotech Holdings Inc., doing business as PharmAla, engages in the manufacture and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community. It offers its MDMA drug active pharmaceutical ingredient under the LaNeo brand name. The company is headquartered in Vancouver, Canada.

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Nicholas Kadysh
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: MDMA